Investors in Health

The Accelerator aims to speed up development of digital innovations across health and care, and pioneer their adoption by the NHS. Digital Health. London connects NHS staff, digital health companies and academics, and equips them to improve the NHS and social care in London through digital technology. Our programmes provide bespoke advice, mentoring, education, peer networking, brand awareness and partnership opportunities, to digital health leaders who are tackling the biggest challenges facing patients, and NHS and Social Care staff.

One of Europe's largest zero equity, multi-corporate ecosystem innovation platforms that runs a scale-up program for high-growth startups. Science and engineering driven technologies have the potential to solve humanity’s biggest challenges. They require unprecedented collaboration between established organizations and the most audacious entrepreneurs out there.

OCCIDENT's aim is to make a positive contribution to society through sustainable and meaningful investments. OCCIDENT invests in innovative deep tech start-ups with excellent technologies in the fields of life sciences, digitaland high-tech with broad application possibilities and the potential for further value-generating developments. The geographic focus is Germany and Switzerland. The preferred stage for initial financing is from seed rounds or later and from 0.5 million euros. OCCIDENT distinguishes itself in particular by its in-depth knowledge of the technology and the versatile support offered to its portfolio companies by its competent team of experts.

Kunsen is an accelerator that supports digital health startups and provides access to funding. At Kunsen, we are driving the revolution taking place at the intersection of technology and healthcare. We have created a unique space for healthcare startups to access the market. In addition to working with healthcare partners, we have co-created the acceleration program with founders of healthcare startups who have outlined their main challenges.

DigitalWell Ventures is an accelerator firm that invests in digital health tech and welfare companies. Accelerator for Nordic and Baltic Health Tech Startups / Startup Program Developer for Innovation Ecosystem Actors. We develop founder oriented accelerator programs supporting our startup teams with company building, preparing to raise capital by raising their investor readiness and accelerate their network and market traction for scaling and growth.

Labena Ventures is a biotech, healthtech pharmatech , food and environment accelerator. We take high-potential startup ventures on a fast-paced learning journey to help them explore and access business opportunities. Through highly-customized programmes, dedicated mentoring experts, and access to our vast network of business partners and investors, we help startups from all stages and across various industries on their way to international success.

dotforge is an intensive 13 week mentor-supported accelerator programme. Dotforge was the only Tech4Good accelerator programme based in the North of England. We believed in supporting the Tech4Good ecosystem outside of London whilst leveraging links to the capital.

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people age better and live longer.

KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech. Having been entrepreneurs, VCs and mentors in both, high growth tech and biotech companies theirselves for many years with multiple exits and massive value created for the founders, they now bring this experience to the emerging field of rejuvenationbiotech - a young industry that will eventually become much bigger than today's largest technology markets.​

EMBL Ventures is a German venture capital firm engaged in the financing and development of products and technologies in the healthcare sector. They manage three funds with a total of €120 million on behalf of major European private and institutional investors. They prefer a role as lead or co-lead investor in financing rounds, which typically range from €5 million to €40 million.

Wessel Management GmbH is the vehicle for venture capital and other investments made by the family of Rolf Christof Dienst. For 40 years, they have been investing directly and, through Rolf, founding partner of Wellington Partners, also indirectly with entrepreneurs who show the greatest potential to achieve success with interesting ideas and/or technologies. They particularly like to engage with companies that contribute to the wellbeing and prosperity of society in general. They mostly invest in conjunction with a small group of co-investors—all experienced entrepreneurs themselves with specific industry knowledge and wide-ranging personal networks. Together with these partners, they actively support their portfolio companies.

TA Ventures is a network-driven VC firm specializing in early-stage tech startups across Europe and North America. They typically provide initial checks ranging from $100,000 to $250,000 for Pre-Seed and Seed stage companies, with capabilities for follow-on investments. TA Ventures emphasizes speed of execution, proactive support, and access to a broad international network. Leveraging their industry knowledge, they actively seek large, growth-oriented co-investors for subsequent funding rounds. Additionally, TA Ventures facilitates access to skilled and cost-effective R&D outsourcing teams in Central and Eastern Europe for portfolio companies and partner VCs.